BioCentury
ARTICLE | Clinical News

ABBV-974: Phase I started

January 19, 2015 8:00 AM UTC

Galapagos began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate single and multiple ascending doses of once-daily oral GLPG1837 in at least 40 healthy volunteers. The start of th...